Evidence map›Paper›PMID 30999821›Full record

ArticleEmerging microbes & infections2019

Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.

Nereida Jiménez de Oya, William P Esler, Kim Huard, Ayman F El-Kattan, Georgios Karamanlidis, Ana-Belén Blázquez, Priscila Ramos-Ibeas, Estela Escribano-Romero, Andrés Louloudes-Lázaro, Josefina Casas and 6 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Nereida Jiménez de Oyaa Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.ORCID http://orcid.org/0000-0003-3129-813X
William P Eslerb Worldwide Research and Development Pfizer , Cambridge , MA , USA.
Kim Huardb Worldwide Research and Development Pfizer , Cambridge , MA , USA.
Ayman F El-Kattanb Worldwide Research and Development Pfizer , Cambridge , MA , USA.
Georgios Karamanlidisb Worldwide Research and Development Pfizer , Cambridge , MA , USA.
Ana-Belén Blázqueza Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.ORCID http://orcid.org/0000-0002-0847-0977
Priscila Ramos-Ibeasc Department of Animal Reproduction , INIA , Madrid , Spain.
Estela Escribano-Romeroa Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.ORCID http://orcid.org/0000-0002-5036-7607
Andrés Louloudes-Lázaroa Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.
Josefina Casasd Department of Biomedicinal Chemistry , Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) and CIBEREHD , Barcelona , Spain.
Francisco Sobrinoe Department of Virology and Microbiology , Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM) , Madrid , Spain.
Kyle Hoehnf School of Biotechnology and Biomolecular Sciences , University of New South Wales , Sydney , Australia.ORCID http://orcid.org/0000-0002-0214-3238
David E Jamesg Charles Perkins Centre, School of Life and Environmental Sciences, Sydney Medical School , University of Sydney , Australia.
Alfonso Gutiérrez-Adánc Department of Animal Reproduction , INIA , Madrid , Spain.
Juan-Carlos Saiza Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.ORCID http://orcid.org/0000-0001-8269-5544
Miguel A Martín-Acebesa Department of Biotechnology , Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) , Madrid , Spain.ORCID http://orcid.org/0000-0001-6015-3613
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria · ESPfizer (United States) · USInstitute for Animal Reproduction · JPAmgen (United States) · USCentro de Biología Molecular Severo Ochoa · ESCentro de Investigación Biomédica en Red · ESThe University of Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flaviviruses are (re)-emerging RNA viruses strictly dependent on lipid metabolism for infection. In the search for host targeting antivirals, we explored the effect of pharmacological modulation of fatty acid metabolism during flavivirus infection. Considering the central role of acetyl-Coenzyme A carboxylase (ACC) on fatty acid metabolism, we analyzed the effect of three small-molecule ACC inhibitors (PF-05175157, PF-05206574, and PF-06256254) on the infection of medically relevant flaviviruses, namely West Nile virus (WNV), dengue virus, and Zika virus. Treatment with these compounds inhibited the multiplication of the three viruses in cultured cells. PF-05175157 induced a reduction of the viral load in serum and kidney in WNV-infected mice, unveiling its therapeutic potential for the treatment of chronic kidney disease associated with persistent WNV infection. This study constitutes a proof of concept of the reliability of ACC inhibitors to become viable antiviral candidates. These results support the repositioning of metabolic inhibitors as broad-spectrum antivirals.

Indexed as

Acetyl-CoA CarboxylaseAnimalsAntiviral AgentsDengueDengue VirusDisease Models, AnimalEnzyme InhibitorsFemaleHumansMaleMiceVirus ReplicationWest Nile FeverWest Nile virusZika VirusZika Virus InfectionAcetyl-CoA CarboxylaseAntiviral AgentsEnzyme Inhibitorsantiviralsdengue virusFlavivirusWest Nile virusZika virus

Identifiers

PMID30999821
PMCPMC6493301
OpenAlexW2935918499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.